Nichols Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$612K Hold
9,780
1.2% 22
2016
Q3
$617K Buy
9,780
+670
+7% +$43.4K 1.15% 23
2016
Q2
$564K Hold
9,110
1.15% 28
2016
Q1
$520K Sell
9,110
-1,000
-10% -$55.7K 0.11% 74
2015
Q4
$599K Hold
10,110
0.13% 71
2015
Q3
$550K Buy
10,110
+2,445
+32% +$159K 0.12% 79
2015
Q2
$515K Hold
7,665
0.09% 88
2015
Q1
$449K Hold
7,665
0.08% 99
2014
Q4
$502K Sell
7,665
-1,355
-15% -$85.4K 0.1% 92
2014
Q3
$521K Hold
9,020
0.11% 88
2014
Q2
$509K Hold
9,020
0.1% 87
2014
Q1
$464K Sell
9,020
-1,400
-13% -$70.8K 0.1% 93
2013
Q4
$550K Hold
10,420
0.11% 86
2013
Q3
$466K Hold
10,420
0.13% 88
2013
Q2
$430K Buy
+10,420
New +$456K 0.13% 88

Other funds holding ABBV

Nichols Asset Management's ABBV Position: Q4 2016 in Review

Nichols Asset Management held its AbbVie (ABBV) position steady in Q4 2016 at 9,780 shares worth $612K. The position accounts for 1.2% of the portfolio, ranked #22.

Nichols Asset Management first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $617K in Q3 2016. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Nichols Asset Management held 9,780 shares of AbbVie worth $612K as of Q4 2016.
  • Nichols Asset Management left its AbbVie share count unchanged in Q4 2016.
  • AbbVie made up 1.2% of Nichols Asset Management's portfolio in Q4 2016, its #22 holding.
  • Nichols Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • Nichols Asset Management's AbbVie position peaked at $617K in Q3 2016.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Nichols Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.